Meaning
Deficits in the realized value or scope of asset sales required by antitrust regulators to approve a merger represent a substantial transactional risk for merging corporations. When a company is forced to sell business units to a competitor, it may encounter divestiture shortfalls if the buyer cannot be found or if the sale price is much lower than expected. This situation occurs when the market recognizes that the seller is under a strict regulatory deadline to divest.
Transaction Deficit
Financial impacts occur when forced asset sales do not generate the capital that the parties originally estimated. These divestiture shortfalls directly reduce the net proceeds of the merger, altering the economic model of the entire transaction. This deficit must often be absorbed by the seller, who has little bargaining power left once the regulatory order has been issued.
Mitigation Hazard
Regulators may reject a proposed buyer if they believe that buyer lacks the operational capacity to run the divested assets. When this rejection happens, the resulting divestiture shortfalls force the merging parties to seek alternative buyers, often on worse financial terms. This delay extends the period of regulatory uncertainty and can cause the value of the assets to deteriorate.
Contractual Adjustment
Contractual agreements allocate the risk of these asset sales between the parties.